Boan Biotech Receives 682 Million RMB in Strategic Investments, Accelerating Global Development of Its Biopharmaceutical Business - Press Releases - Luye Pharma Group
Summary
Founded in the BioBay of Suzhou Industrial Park and with a global portfolio, YuanBio Venture Capital focuses on early and growth stage life science and healthcare investments. Since the end of 2019, three of YuanBio Venture Capitals portfolio companies have been listed, BrightGene and Allist Pharmaceuticals on the Science and Technology Board of the Shanghai Stock Exchange, and Kintor Pharmaceutical on the Main Board of the Hong Kong Stock Exchange, while the initial listings of several other companies in YuanBios portfolio, such as Shengnuo Biopharm, Kawin, and Sunvou have also been approved.Founded by Mr. Jianming Yu in January, 2016, Advantech Capital Investment is a private equity fund focused on the China market. Advantech Capitals investment portfolio of companies in the health sector include ZAI Lab, Harbour BioMed, Synermore, KBP Biosciences, Zhejiang DTRM Biopharma, Nanjing Micro-Tech, Sinovac, Nanos Medical, ASC Therapeutics, Alphamab Oncology, TOT Biopharm, Mojo Vision, Connect Biopharmaceuticals, InventisBio, and Wellem Medical. Zhongyuan Qianhai Equity Fund LLP is a limited partnership established in Zhengdong New District, Zhengzhou City, Henan Province. The fund is managed by an executive team led by Mr. Jin Haitao, with Shenzhen Capital Group Co., Ltd. as the institutional partner, and Mr. Ma Weihua, Mr. Shen Nanpeng, Mr. Xiong Xiaoge, Mr. Li Wei, Mr. Ni Zhengdong and other well-known investors as co-partners.Founded by Dr. Yang Zhi in 2005, BVCF is an investment company which initiates and manages funds with a focus on international growth stage life sciences companies.